← Back to the feed

EVIS Bioscience AG

History from 12 Jun 2024

UID

CHE-190.466.790

Legal form

AG

Canton

ZH

Founded

12 Jun 2024

Amount raised

not in the SHAB

Lead investor

not in the SHAB

Record

1. SHAB published 17 Jun 2024 · legal date 12 Jun 2024

   Company formed

   Founded 12 Jun 2024

   SHAB HR01-1006057972 ↗

2. Announced 20 Mar 2026

   Round announced

   matched to a capital increase · high match confidence

   Announcement ↗

3. SHAB published 2 Sep 2026 · legal date 10 Aug 2026

   Capital increase

   ●●●Confirmed round · missed by classifier

   Paid by converting claims

   Nominal capital

   100’000 → 106’589

   Shares

   100’000 → 106’589

   New shares, % of post-step shares

   6.2% (6’589 new)

   Aktienkapital neu: CHF 106'589.00 [bisher: CHF 100'000.00]. Liberierung Aktienkapital neu: CHF 106'589.00 [bisher: CHF 100'000.00]. Aktien neu: 106'589 Namenaktien zu CHF 1.00 [bisher: 100'000 Namenaktien zu CHF 1.00].

   • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
   • The company was founded less than six years before this capital increase.+0.5
   • The company's purpose describes technology or life-sciences development.+0.5
   • Paid entirely by converting existing claims, with no new money.−1.5

   Classifier score 0.20 · likely-financing threshold 0.60 · not a calibrated probability

   SHAB HR02-1006745478 ↗

Published by 8 Oct 2026